Anika Therapeutics | ANIK - Trade Creditors


Anika Therapeutics reported $6.34M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.24B 117M Dec/2025
Agenus USD 71.08M 11.9M Mar/2026
Agios Pharmaceuticals USD 13.75M 4.61M Mar/2026
Anika Therapeutics USD 6.34M 298K Mar/2026
Arrowhead Research USD 30.75M 2.19M Mar/2026
Enanta Pharmaceuticals USD 1.88M 63K Dec/2025
Halozyme Therapeutics USD 14.1M 6.8M Mar/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Insmed USD 73.38M 6.53M Mar/2026
Integra LifeSciences USD 87.95M 7.78M Mar/2026
Intrexon USD 4.85M 3.12M Jun/2024
J&J USD 10.46B 1.53B Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Ligand Pharmaceuticals USD 37.11M 33.87M Mar/2026
MacroGenics USD 4.29M 500K Mar/2026
Merit Medical Systems USD 67.85M 7.3M Mar/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 22.71B 219M Mar/2026
Smith & Nephew USD 1.19B 73M Dec/2025
Stryker USD 1.8B 301M Dec/2025
Veracyte USD 6.91M 2.32M Mar/2026
Xencor USD 7.92M 2.91M Mar/2026
Zimmer Biomet Holdings USD 361.2M 58.2M Mar/2026